In Part I of this series providing a summary of the mRNA IP and competitive landscape through one year of the COVID-19 pandemic, we focused on market players BioNTech, Moderna and CureVac; in Part II, ...

This interview is part of the Inside the Mind of the CxO series, which explores a wide range of critical decisions faced by chief executives around the world. Nigeria is widely viewed as coming late ...

Opinions expressed by Entrepreneur contributors are their own. The digital age has ushered in a new era where data reigns supreme, providing businesses with valuable insights into customer behavior, ...

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report delivers extensive insights into ...